AI
Monday, March 15, 2010 4:52:15 PM
SQNM off, 7.30's, on miss:
SQNM Sequenom misses by $0.05, beats on revs (7.75 -0.06)
Reports Q4 (Dec) loss of $0.30 per share, $0.05 worse than the First Call consensus of ($0.25); revenues fell 11.5% year/year to $10.8 mln vs the $9.1 mln consensus. Co said, "With the completion of a strategic review in late 2009, we are now focused on funding priority projects in 2010, which includes continuing to make a major investment in T21 development and clinical studies. An additional project which will receive priority funding for 2010 includes development of the next generation of MassARRAY instrumentation."
SQNM Sequenom misses by $0.05, beats on revs (7.75 -0.06)
Reports Q4 (Dec) loss of $0.30 per share, $0.05 worse than the First Call consensus of ($0.25); revenues fell 11.5% year/year to $10.8 mln vs the $9.1 mln consensus. Co said, "With the completion of a strategic review in late 2009, we are now focused on funding priority projects in 2010, which includes continuing to make a major investment in T21 development and clinical studies. An additional project which will receive priority funding for 2010 includes development of the next generation of MassARRAY instrumentation."
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
